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ABSTRACT
Background: Excessive alcohol intake has been shown to be associated with cardiovascular disease via metabolic pathways.
However, the relationship between alcohol intake and obesity has not been fully elucidated. We aimed to examine the
association of alcohol consumption with fat deposition and anthropometric measures.
Methods: From 2006–2008, we conducted a cross-sectional study in a population-based sample of Japanese men aged 40
through 79 years. Areas of abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were calculated
using computed tomography imaging. Based on a questionnaire, we classiﬁed participants into ﬁve groups according to
weekly alcohol consumption, excluding former drinkers: non-drinkers (0 g=week), 0.1–160.9, 161–321.9, 322–482.9, and
≥483 g=week. Multivariable linear regression was used to estimate adjusted means of obesity indices for each group.
Results: We analyzed 998 men (mean age and body mass index [BMI], 63.8 years and 23.6 kg=m2, respectively). Higher weekly
alcohol consumption was strongly and signiﬁcantly associated with higher abdominal VAT area, percentage of VAT, and VAT-
to-SAT ratio (all P for trend <0.001), and also with waist circumferences and waist-to-hip ratio (P for trend = 0.042 and 0.007,
respectively). These associations remained signiﬁcant after further adjustment for BMI, whereas alcohol consumption had no
signiﬁcant association with abdominal SAT area.
Conclusions: Higher alcohol consumption was associated with higher VAT area, VAT%, and VAT-to-SAT ratio, independent
of confounders, including BMI, in general Japanese men. These results suggest that alcohol consumption may have a potential
adverse eﬀect on visceral fat deposition.
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INTRODUCTION
Overweight and obesity are estimated to cause 3.4 million deaths
globally each year,1 and the prevalence of obesity has increased
worldwide.2 Obesity has a major impact on cardiovascular
health.3,4 In addition, fat deposition has been recognized as
an important risk factor for cardiovascular disease (CVD)5,6 and
is related to metabolic syndrome7–9 and subclinical atheroscle-
rosis.8,10 Speciﬁcally, visceral adipose tissue (VAT) showed a
stronger association with CVD than subcutaneous adipose tissue
(SAT).5 Moreover, greater VAT-to-SAT ratio (VSR) was also
reported to be associated with CVD.11
Numerous epidemiological ﬁndings indicate that large amounts
of alcohol intake are associated with a higher risk of CVD12,13
via metabolic pathways related to increased blood pressure,14
decreased glucose tolerability,15 and deteriorated lipid metabo-
lism.16 However, limited evidence is available on how alcohol
intake aﬀects fat deposition, such as abdominal VAT and SAT.
Only a few population-based studies investigated the association
of alcohol consumption with VAT and SAT in Western
countries,17 where BMI is generally higher than in other regions,
including Japan. Other studies were also based on speciﬁc
populations, such as overweight people,18 company employees,19
and hospital-based participants who underwent a health check-
up.20 In addition, among all previous studies, former drinkers
were not distinguished from lifetime abstainers, which could
potentially have caused bias due to cessation from illness due
to excessive alcohol intake. Furthermore, although a number of
studies have investigated the relationships between alcohol intake
and anthropometric measures, including body mass index
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(BMI),21–25 waist circumferences (WC),16,22,23,25,26 waist-to-
height ratio (WHtR), or waist-to-hip ratio (WHR),22,27–29 these
results remain inconsistent.
Therefore, we aimed to examine cross-sectional associations of
alcohol consumption with measures of abdominal fat deposition,
including computed tomography (CT)-based assessments of VAT
and SAT and anthropometric indices, in a population-based
sample of Japanese men, excluding former drinkers.
METHODS
Study participants and measurements
The Shiga Epidemiological Study of Subclinical Atherosclerosis
(SESSA) is an ongoing prospective, population-based study of a
random sample from a general Japanese population, as described
elsewhere.30,31 Participants eligible for the present study were
1,094 men aged 40 through 79 years (mean 63.8; standard
deviation [SD], 9.8 years) enrolled at baseline (May 2006–March
2008) in SESSA. After excluding 60 participants who were
former drinkers and 36 participants with missing information, a
total of 998 participants were analyzed in the present study. Of the
998 participants, 952 measured hip circumferences to calculate
WHR. The present study was approved by the Institutional
Review Board of Shiga University of Medical Science (Otsu,
Japan), and all participants provided written informed consent.
A self-administered questionnaire was used to obtain
information on demography, alcohol drinking, smoking habits,
physical activity, medication use, medical history, and other
lifestyle factors. After the participants completed the question-
naires, trained nurses conﬁrmed answers to the questionnaire with
the participants. Based on the questionnaire, the frequency of
alcohol consumption during a typical week or month and the total
alcohol intake on each occasion were determined and used to
calculate the alcohol intake per week.32 Speciﬁcally, weekly
intake of alcohol was assessed in units of “go” (a traditional
Japanese unit of volume corresponding to 23 g of ethanol, that is,
7 go, 14 go, and 21 go correspond to 161 g, 322 g, and 483 g
of ethanol, respectively), and was converted to grams of ethanol
per week. One go is equivalent to 180mL of Sake (Japanese
rice wine) and corresponds to one bottle (500mL) of beer, two
single shots (75mL) of whisky, or two glasses (180mL) of wine.
Participants who reported consuming 0.1 g=day or more of
ethanol were regarded as drinkers.
Body weight and height were measured while the participants
were wearing light clothing without shoes. Circumferences of
waist and hip were measured twice at the levels of the umbilicus
and maximal protrusion of the hip, respectively, in the end-
exhalation phase while the participant was standing upright.
The mean of the two measurements was used for analysis. BMI,
WHtR, and WHR were calculated as weight (kg) divided by
height squared (m2), WC (cm) divided by height (cm), and WC
(cm) divided by hip circumference (cm), respectively. Blood
pressure was measured twice consecutively in the right arm of
the seated participant, after sitting quietly for 5min, using an
automated sphygmomanometer (BP-8800; Omron Health Care
Co. Ltd, Tokyo, Japan). The mean of these two measurements
was used for analyses.
Blood specimens were obtained early in the clinic visit, after
fasting for at least at 12 h, and used for laboratory testing. Serum
lipid concentrations were determined at a single laboratory (Shiga
Laboratory; MEDIC, Shiga, Japan) that had been certiﬁed for
standardized lipid measurements according to the protocols of
the United States Centers for Disease Control and Prevention=
Cholesterol Reference Method Laboratory Network. Total
cholesterol and triglycerides were measured using enzymatic
assays, and high-density lipoprotein cholesterol (HDL-C) was
determined using a direct method. Plasma glucose levels were
determined from NaF-treated plasma using a hexokinase glucose-
6 phosphate-dehydrogenase enzymatic assay. Aminotransferase
and Gamma-glutamyl transferase were measured using modiﬁed
Japan Society of Clinical Chemistry reference method. HDL-C
and Gamma-glutamyl transferase are known as biomarkers
used to validate alcohol consumption.33,34 Smoking status was
categorized into three groups: current, former, and never smokers.
Participants who smoked in the last 30 days were deﬁned as
current smokers, whereas participants who had never smoked
before were deﬁned as never smokers, and smokers were queried
for the average number of cigarettes smoked each day. Step
count was recorded over 7 consequent days using a pedometer
(DIGI-WALKER DW-200; Yamasa Tokei Keiki Co. Ltd, Tokyo,
Japan). Then, we calculated the average steps per day.
Abdominal adipose tissue areas
Areas of VAT and SAT were assessed using CT, as previously
described.35 Abdominal VAT was deﬁned as the fat enclosed by
the inner aspect of the abdominal wall. Abdominal SAT was
deﬁned as the fat outside the outer aspects of the abdominal wall,
but not including that fat located within the muscular fascia.
While participants were supine, serial CT images were obtained
using a protocol similar to one described previously.36 A single
CT image of the L4–L5 vertebral space was selected to estimate
areas of VAT and SAT. Adipose tissue was identiﬁed as showing
attenuation between −190 and −30 Hounsﬁeld units combined
with anatomical interpretation by a reader. Studies of human
cadavers have shown that the area measured by CT oﬀers an
accurate estimate of abdominal VAT,37 and the same or similar
ranges of attenuation have been adopted to estimate VAT=SAT
in population studies.10,38–40 The inner and outer aspects of the
abdominal walls were manually tracked, and respective areas
were calculated using image analysis software (SliceOmatic;
Tomovision, Montreal, Canada). Two types of CT scanner were
used during the examination period: a GE-Imatron C150 Electron
Beam Tomography system (EBCT; GE Medical Systems, South
San Francisco, CA, USA; slice thickness, 6mm) for participants
examined from May 2006 through August 2007 and a 16-row
multidetector row CT system (MDCT, Aquilion-16™; Toshiba
Medical Systems, Tochigi, Japan; slice thickness, 7mm) for
participants examined thereafter. All CT images were analyzed at
Shiga University of Medical Science by a trained physician-
researcher who was blinded to participant characteristics.
Abdominal total adipose tissue (TAT) area, percentage of VAT
(VAT%), and VSR were calculated as sum of VAT area (cm2)
and SAT area (cm2), VAT area (cm2) divided by TAT area (cm2)
and multiplied by 100, and VAT area (cm2) divided by SAT area
(cm2), respectively.
Statistical analysis
The participants were classiﬁed into ﬁve groups according to
weekly alcohol intake: non-drinkers (0 g=week), 0.1–160.9,
161–321.9, 322–482.9, and ≥483 g=week. P values for trend
across groups were determined either using linear regression
when a response variable is continuous, or using logistic
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regression when it is categorical. An age-adjusted Pearson’s
correlation was used to describe the relationship among obesity
indices including anthropometric measures (BMI, WC, WHtR,
and WHR) and abdominal fat deposition (VAT, SAT, TAT,
VAT%, and VSR). A dose-response relationship between daily
alcohol consumption and obesity measures was investigated
using analysis of covariance. Adjusted covariates were age, daily
cigarettes, daily steps, history of CVD, and history of liver
disease. Dietary data were not available in our study. Because
BMI is commonly used as an index of obesity and results from an
imbalance between energy intake and expenditure, we also took
this index into account in the adjusted model as a surrogate
measure of energy intake by combined use with daily steps as
energy expenditure. Further adjustment for use of any medication,
such as glucocorticoid, anti-hyperlipidemic agents, and anti-
hyperglycemic agents, did not substantially aﬀect the ﬁndings, so
these variables were not included in the model. Sensitivity
analyses were performed in 926 participants without liver disease
history and in 912 participants without CVD history. Analysis
was performed using SPSS (version 22.0; SPSS, Inc., Chicago,
IL, USA). Two-tailed P values of <0.05 were considered
statistically signiﬁcant.
RESULTS
Demographics of 998 study participants based on alcohol intake
are shown in Table 1. The mean BMI and weekly alcohol
consumption was 23.6 kg=m2 and 173.4 g=week, respectively.
Participants with higher alcohol intake were younger; taller; had
higher systolic and diastolic blood pressure, HDL-C, triglyceride,
fasting glucose, gamma-glutamyl transferase, transaminase, and
cigarettes consumption; had a higher prevalence of current
smoker; had a lower level of total cholesterol; and had a lower
prevalence of CVD history. Among obesity measures, weekly
alcohol consumption was positively associated with abdominal
VAT, TAT, VAT%, VSR, WC, and WHR.
According to age-adjusted Pearson’s correlation coeﬃcients (r)
between obesity indices (eTable 1), BMI, WC, and WHtR were
strongly and positively correlated with abdominal TAT, VAT,
and SAT area (all correlation coeﬃcients range from 0.72 to
0.88), but not with VAT% or VSR (all correlation coeﬃcients
range from −0.05 to 0.04). WHR was strongly and positively
correlated with abdominal TAT, VAT, and SAT area (correlation
coeﬃcients, 0.88, 0.67, and 0.63, respectively) and was weakly
with VAT% and VSR (correlation coeﬃcients, 0.13 and 0.12,
Table 1. Study sample characteristics according to weekly alcohol consumption in 998 men aged 40–79 years (SESSA, Shiga, Japan,
2006–2008)
Categories of weekly alcohol consumption (g=week)
Trend PNon-drinkers 0.1–160.9 161–321.9 322–482.9 ≥483
n 192 378 226 129 73
Age, years 65.4 (10.2) 63.4 (10.5) 64.4 (9.5) 62.6 (8.3) 61.2 (8.2) 0.004
Height, cm 165.9 (5.9) 166.5 (6.1) 166.3 (5.9) 167.2 (5.9) 167.5 (4.8) 0.026
Weight, kg 64.5 (9.5) 65.4 (9.8) 65.3 (9.8) 67.0 (10.2) 66.1 (9.3) 0.060
BMI, kg=m2 23.4 (2.9) 23.5 (3.0) 23.6 (2.9) 23.9 (3.1) 23.5 (3.1) 0.335
VAT area, cm2 108.3 (48.4) 117.5 (55.0) 120.5 (55.2) 132.0 (59.9) 125.9 (55.6) <0.001
SAT area, cm2 120.2 (54.1) 124.1 (53.2) 119.2 (49.9) 125.1 (55.0) 114.5 (51.1) 0.615
TAT area, cm2 228.5 (94.0) 241.6 (98.6) 239.7 (96.4) 257.1 (104.5) 240.3 (96.1) 0.076
VAT% 47.4 (8.9) 48.2 (8.7) 49.7 (7.9) 51.2 (9.3) 52.0 (9.0) <0.001
VSR 0.96 (0.36) 0.99 (0.37) 1.04 (0.35) 1.12 (0.42) 1.16 (0.44) <0.001
WC, cm 84.4 (8.1) 85.3 (8.1) 85.9 (7.9) 86.2 (8.0) 85.7 (8.0) 0.045
WHtR 0.51 (0.05) 0.51 (0.05) 0.52 (0.05) 0.52 (0.05) 0.51 (0.05) 0.249
WHRa 0.92 (0.06) 0.92 (0.05) 0.93 (0.05) 0.93 (0.06) 0.92 (0.05) 0.015
Blood pressure, mmHg
Systolic 135.3 (18.3) 133.7 (17.6) 136.8 (18.9) 140.9 (19.9) 146.0 (21.6) <0.001
Diastolic 77.3 (10.2) 78.6 (10.5) 80.7 (10.6) 82.7 (12.2) 85.5 (10.9) <0.001
Total-cholesterol, mg=dL 210.0 (33.7) 208.7 (31.6) 207.6 (34.2) 201.4 (32.5) 204.7 (35.6) 0.029
HDL-C, mg=dL 53.2 (13.5) 57.9 (15.7) 61.2 (17.8) 61.4 (15.8) 66.7 (23.4) <0.001
Triglycerides, mg=dL 124.2 (66.0) 119.8 (68.6) 126.8 (82.1) 142.5 (124.6) 151.8 (81.6) 0.001
Fasting glucose, mg=dL 101.0 (17.3) 101.2 (21.1) 105.5 (24.1) 103.4 (18.7) 105.8 (25.2) 0.022
Gamma-glutamyl transferase, U=L 38.0 (42.4) 40.2 (35.6) 63.1 (74.7) 85.6 (73.8) 136.9 (175.0) <0.001
Alanine aminotransferase, U=L 26.1 (15.9) 25.0 (14.4) 26.7 (18.2) 26.2 (14.8) 35.3 (28.9) 0.002
Aspartate aminotransferase, U=L 25.6 (8.7) 25.1 (8.4) 29.2 (23.0) 29.2 (12.4) 40.0 (32.3) <0.001
Daily steps 7297 (2981) 8036 (3192) 8257 (3372) 8154 (3071) 7728 (3373) 0.078
Daily number of cigarettes 6.9 (11.0) 5.1 (9.8) 6.6 (10.4) 8.7 (11.7) 10.4 (14.9) 0.001
Smoking, %
Current 33.3 26.5 34.5 41.9 41.1 0.007
Former 42.7 51.6 53.5 52.7 46.6 0.179
History of CVD, % 14.6 7.1 7.5 7.0 6.8 0.035
History of liver disease, % 6.3 5.3 9.3 9.3 9.6 0.272
BMI, body mass index; CVD, cardiovascular disease; HDL-C, high density lipoprotein cholesterol; SAT, abdominal subcutaneous adipose tissue; SESSA, Shiga
Epidemiological Study of Subclinical Atherosclerosis; SD, standard deviation; TAT, abdominal total adipose tissue; VAT, abdominal visceral adipose tissue;
VAT%, percentage of visceral adipose tissue; VSR, VAT-SAT ratio; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio.
Values are expressed as mean (standard deviation), or percentage.
P values for trend were obtained using linear regression (for continuous variables) or logistic regression (for categorical variables).
aA total of 952 (non-drinkers, 184; 0.1–160.9 g=week, 368; 161–321.9 g=week, 213; 322–482.9 g=week, 119; ≥483 g=week, 68) men underwent measurement of
hip circumferences.
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respectively). Abdominal VAT area was positively correlated
with abdominal SAT area, TAT area, VAT%, and VSR
(correlation coeﬃcients, 0.66, 0.92, 0.47 and 0.45, respectively),
whereas abdominal VAT% and VSR were weakly but negatively
correlated with abdominal SAT (correlation coeﬃcients, −0.28
and −0.29, respectively).
Adjusted means of obesity indices are shown according to
weekly alcohol consumption in Table 2. Higher weekly alcohol
consumption was strongly and signiﬁcantly associated with
higher abdominal VAT area, VAT%, and VSR (all P for trend
<0.001), and also with anthropometric indices such as WC and
WHR (P for trend = 0.042 and 0.007, respectively). These
associations also persisted after further adjustment for BMI
(Table 3). On the other hand, there was no signiﬁcant association
between weekly alcohol consumption and abdominal SAT area
(Table 2 and Table 3). In the sensitivity analyses, similar results
were observed among participants without liver disease history
(eTable 2) and CVD history (eTable 3).
DISCUSSION
Principal ﬁndings
In this population-based study in Asia, with one of the lowest
levels of BMI among the relevant studies, we cross-sectionally
observed signiﬁcant dose-dependent associations between weekly
alcohol consumption and abdominal VAT area, VAT%, VSR,
TAT, WC, and WHR; these associations were independent of
age, daily steps, smoking, CVD history, and history of liver
disease. These associations were still signiﬁcant after further
adjustment for BMI, as a surrogate measure of energy intake. In
contrast, we observed no signiﬁcant association between alcohol
intake and abdominal SAT area.
In the context of current literature
Our results support past demonstrations with respect to the
positive association between alcohol consumption and VAT-
related indices. Molenaar et al, in 2,926 participants from the
Table 2. Adjusted mean valuesa of obesity indices according to weekly alcohol consumption in 998 men aged 40–79 years (SESSA,
Shiga, Japan, 2006–2008)
Categories of weekly alcohol consumption (g=week)
Trend PNon-drinkers 0.1–160.9 161–321.9 322–482.9 ≥483
n 192 378 226 129 73
VAT area, cm2 105.3 (3.9) 117.7 (2.7) 122.2 (3.5) 133.2 (4.7) 125.3 (6.2) <0.001
SAT area, cm2 118.7 (3.7) 123.8 (2.6) 121.0 (3.4) 125.8 (4.5) 112.8 (6.0) 0.360
TAT area, cm2 224.0 (6.9) 241.5 (4.9) 243.3 (6.3) 259.1 (8.3) 238.1 (11.1) 0.028
VAT% 47.2 (0.6) 48.3 (0.4) 49.7 (0.6) 51.2 (0.8) 52.1 (1.0) <0.001
VSR 0.95 (0.03) 0.99 (0.02) 1.04 (0.02) 1.13 (0.03) 1.17 (0.04) <0.001
BMI, kg=m2 23.3 (0.2) 23.5 (0.2) 23.7 (0.2) 23.9 (0.3) 23.4 (0.3) 0.489
WC, cm 84.0 (0.6) 85.4 (0.4) 86.2 (0.5) 86.3 (0.7) 85.4 (0.9) 0.042
WHtR 0.51 (0.00) 0.51 (0.00) 0.52 (0.00) 0.52 (0.00) 0.51 (0.01) 0.066
WHRb 0.91 (0.00) 0.92 (0.00) 0.93 (0.00) 0.93 (0.00) 0.93 (0.01) 0.007
BMI, body mass index; CVD, cardiovascular disease; SAT, abdominal subcutaneous adipose tissue; SE, standard error; SESSA, Shiga Epidemiological Study of
Subclinical Atherosclerosis; TAT, abdominal total adipose tissue; VAT, abdominal visceral adipose tissue; VAT%, percentage of visceral adipose tissue; VSR,
VAT-SAT ratio; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio.
Values are expressed as mean (SE). P values for trend were obtained using linear regression.
aMean values were adjusted using analysis of covariance for age, daily steps, daily number of cigarettes, history of CVD, and history of liver disease.
bA total of 952 (non-drinkers, 184; 0.1–160.9 g=week, 368; 161–321.9 g=week, 213; 322–482.9 g=week, 119; ≥483 g=week, 68) men underwent measurement of
hip circumferences.
Table 3. Adjusted mean valuesa of abdominal fat deposition indices according to weekly alcohol consumption in 998 men aged 40–79
years after further adjustment for BMI (SESSA, Shiga, Japan, 2006–2008)
Categories of weekly alcohol consumption (g=week)
Trend PNon-drinkers 0.1–160.9 161–321.9 322–482.9 ≥483
n 192 378 226 129 73
VAT area, cm2 108.2 (2.8) 118.1 (2.0) 121.1 (2.5) 128.7 (3.3) 127.1 (4.4) <0.001
SAT area, cm2 121.9 (2.2) 124.3 (1.6) 119.8 (2.0) 120.8 (2.7) 114.8 (3.6) 0.112
TAT area, cm2 230.1 (3.8) 242.4 (2.7) 240.9 (3.5) 249.5 (4.7) 241.8 (6.2) 0.021
VAT% 47.2 (0.6) 48.3 (0.4) 49.7 (0.5) 51.3 (0.8) 52.1 (1.0) <0.001
VSR 0.95 (0.03) 1.00 (0.02) 1.04 (0.02) 1.13 (0.03) 1.17 (0.04) <0.001
WC, cm 84.5 (0.3) 85.5 (0.2) 86.0 (0.3) 85.5 (0.4) 85.8 (0.5) 0.006
WHtR 0.51 (0.00) 0.51 (0.00) 0.52 (0.00) 0.51 (0.00) 0.52 (0.00) 0.004
WHRb 0.92 (0.00) 0.92 (0.00) 0.93 (0.00) 0.93 (0.00) 0.93 (0.00) 0.009
BMI, body mass index; CVD, cardiovascular disease; SAT, abdominal subcutaneous adipose tissue; SE, standard error; SESSA, Shiga Epidemiological Study of
Subclinical Atherosclerosis; TAT, abdominal total adipose tissue; VAT, abdominal visceral adipose tissue; VAT%, percentage of visceral adipose tissue; VSR,
VAT-SAT ratio; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio.
Values are expressed as mean (SE). P values for trend were obtained using linear regression.
aMean values were adjusted for BMI in addition to age, daily steps, daily number of cigarettes, history of CVD, and history of liver disease.
bA total of 952 (non-drinkers, 184; 0.1–160.9 g=week, 368; 161–321.9 g=week, 213; 322–482.9 g=week, 119; ≥483 g=week, 68) men underwent measurement of
hip circumferences.
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Framingham Heart Study, with mean age of 49.5 years and mean
BMI of 27.7 kg=m2, revealed that a large amount of alcohol was
associated with a higher abdominal VAT volume but not with
SAT volume in men, whereas, in women, higher alcohol intake
was associated with lower abdominal SAT volume but not with
VAT volume.17 Among 87 apparently healthy Italian women
aged only 38 years with a mean BMI of 24.2 kg=m2, a positive
association was found between alcohol intake and VAT area.41
For previous results based on speciﬁc populations, in a hospital-
based study of 951 Korean men who received a health check-up,
with mean age of 52.4 years and mean BMI of 25.0 kg=m2,
alcohol consumption was associated with higher abdominal VAT
area and lower abdominal SAT area.20 A signiﬁcant relationship
of higher alcohol intake and VAT area has also been previously
conﬁrmed in Japanese male employees19 and in Japanese
overweight men.18 However, among all previous studies, former
drinkers were not distinguished from lifetime abstainers. Our
ﬁndings of a higher alcohol intake related to abdominal VAT
area, VAT%, and VSR among Japanese general men without
former drinkers, in addition to these pieces of past evidence,
indicate that alcohol consumption is positively associated
with VAT indices, although the relationship between alcohol
consumption and SAT is equivocal.
The eﬀects of alcohol consumption on anthropometrical
indicators remain controversial. Similar to our ﬁndings, no
signiﬁcant relationship between alcohol consumption and BMI
were reported in Japanese men aged 21–65 years,18 whereas
alcohol consumption was inversely or J-shaped associated with
BMI in other studies of American men and women21,24 and
Japanese men,25 and WC in Japanese men25 and American16 and
Danish26 men and women with middle and older age. On the
other hand, positive associations between alcohol intake and BMI
were found in British and Korean with middle to older age.22,23
Consistent with our results, the amount of alcohol was positively
related to WC,22,23 and to WHR in the United States27 and
Europe.22,28,29 Based on these ﬁndings, the inﬂuence of alcohol
on anthropometric obesity measures remains unclear. These
inconsistencies between studies may be because of the diﬀerence
in the study sample demographics, such as obesity distribution
and alcohol intake, and measurement techniques for anthro-
pometric and alcohol measures. Despite these inconsistencies,
the positive association between alcohol consumption and VAT
indices has been robustly coincided with previous studies, and
VAT indices were more strongly associated with metabolic risk
factor clustering,42 atherosclerosis,43 and CVD5 compared with
anthropometric indices.
Potential mechanisms
The exact mechanism of the association between alcohol intake
and abdominal fat deposition remains unclear, but several
speculations have been made. Alcohol intake concomitant
with meal contribute to VAT accumulation through decreased
VAT suppressors, such as leptin and glucagon-like peptide 1
(GLP-1).44–47 Alcohol intake also increases the plasma cortisol
level and decreases serum testosterone-to-cortisol ratio, the
alterations of which promote VAT accumulation.48–51 Further,
higher alcohol intake was presumed to reduce serum adiponectin
levels,52 which were inversely associated with VAT accumu-
lation.53 It is noteworthy that leptin, cortisol, testosterone,
and adiponectin were reported to be more strongly associated
with VAT accumulation than with SAT accumulation.46,49,51,53
Additionally, hypertriglyceridemia induced via alcohol intake is
thought to be a result of increased very-low-density lipoprotein
secretion, impaired lipolysis, and increased free fatty acid ﬂuxes
from adipose tissue to the liver.45,54 VAT is also correlated
with serum triglycerides levels.55 Thus, it is speculated that
alcohol consumption aﬀects metabolic balance susceptible to
fat accumulation around mesenteric and liver. Meanwhile,
alcohol intake is potentially relevant to dietary habit. Although
we did not have detailed dietary records, positive relationships
were observed of alcohol consumption with energy intake18 and
dietary fat,56 which were positively associated with VAT.18,57
However, no signiﬁcant change was observed in the relationship
between alcohol consumption and VAT indices when we add
BMI to the adjustment variables as a surrogate measure of
energy intake. Further investigation is necessary to conﬁrm
this association in other population and identify the potential
mechanism.
Strengths and limitations
Our study has several limitations. First, the study design was
cross-sectional. Therefore, causal and longitudinal relationships
were not addressed. Second, data on alcohol intake were based
on self-report, leading to potential misclassiﬁcation. However,
our observation of positive association of alcohol consumption
with HDL-C and Gamma-glutamyl transferase validate the
classiﬁcation. Third, there is possibility that our ﬁndings may,
in part, be explained by diﬀerences in unknown or residual
confounders, such as dietary habits. Finally, because only
Japanese men were included for analyses, our results are restricted
to men of a single ethnic group. However, population
homogeneity reduces possible confounding from cultural,
environmental, and genetic variation. Strength of our study
include the general population-based design, use of a standardized
protocol in assessing outcomes, such as CT-based abdominal
VAT and SAT area, other adjusting covariates, and the exclusion
of former drinkers for the analysis, which minimized bias due to
cessation because of illness caused by alcohol.
Conclusions
The present study demonstrated that higher alcohol consumption
was associated with a greater degree of abdominal VAT area,
VAT%, and VSR in a population-based sample of Japanese men,
independent of possible confounding factors, including BMI.
Our ﬁndings suggest that alcohol consumption may potentially
and adversely aﬀect fat deposition.
ACKNOWLEDGEMENTS
The authors are deeply indebted to staﬀ members of the SESSA
study. The members of the SESSA study are listed in the
Appendix.
Source of funding: This research was supported by Grants-
in-aid for Scientiﬁc Research (A) 13307016, (A) 17209023,
(A) 21249043, (A) 23249036, (A) 25253046, (A) 15H02528,
and (B) 26293140, (B) 24790616, (B) 21790579 from the
Ministry of Education, Culture, Sports, Science, and Technology
Japan; and by Glaxo-Smith Klein.
Conﬂicts of interest: Dr. H. Arima has received lecture fee
from Deiichi-Sankyo and Fukuda Denshi. Deiichi-Sankyo and
Fukuda Denshi have no role in this study. The authors declare no
other conﬂicts of interest.
Sumi M, et al.
J Epidemiol 2019;29(6):205-212 j 209
Author contributions: MS and TH drafted the manuscript and
carried out the statistical analysis. MS, HT, AF, AK, KM, and
HU conceived and designed the study. All authors critically
revised the manuscript for important intellectual content and
contributed to and approved the ﬁnal version.
APPENDIX A. SUPPLEMENTARY DATA
Supplementary data related to this article can be found at https:==
doi.org=10.2188=jea.JE20170191.
APPENDIX B.
Members of the SESSA Research Group
Chairperson: Hirotsugu Ueshima (Center for Epidemiologic
Research in Asia, Department of Public Health, Shiga University
of Medical Science, Otsu, Shiga).
Co-chairpersons: Katsuyuki Miura (Department of Public
Health, Shiga University of Medical Science, Otsu, Shiga).
Research members: Minoru Horie, Yasutaka Nakano, Takashi
Yamamoto, Hideki Hayashi (Department of Cardiovascular and
Respiratory Medicine, Shiga University of Medical Science,
Otsu, Shiga), Emiko Ogawa (Health Administration Center,
Shiga University of Medical Science, Otsu, Shiga), Hiroshi
Maegawa, Itsuko Miyazawa (Division of Endocrinology and
Metabolism, Department of Medicine, Shiga University of
Medical Science, Otsu, Shiga), Kiyoshi Murata (Department of
Radiology, Shiga University of Medical Science, Otsu, Shiga),
Kenichi Mitsunami (Vories Memorial Hospital, Omihachiman,
Shiga), Kazuhiko Nozaki (Department of Neurosurgery, Shiga
University of Medical Science, Otsu, Shiga), Ikuo Tooyama,
Akihiko Shiino (Molecular Neuroscience Research Center, Shiga
University of Medical Science, Otsu, Shiga), Teruhiko Tsuru
(Department of Urology, Shiga University of Medical Science,
Otsu, Shiga), Hisakazu Ogita, Akio Shimizu (Division of Medical
Biochemistry, Department of Biochemistry and Molecular
Biology, Shiga University of Medical Science, Otsu, Shiga),
Naomi Miyamatsu (Department of Clinical Nursing, Shiga
University of Medical Science, Otsu, Shiga), Toru Kita (Kyoto
University, Kyoto), Takeshi Kimura (Department of Cardiovas-
cular Medicine, Kyoto University, Kyoto), Yoshihiko Nishio
(Department of Diabetes, Metabolism, and Endocrinology,
Kagoshima University, Kagoshima), Yasuyuki Nakamura
(Department of Food Science and Human Nutrition, Faculty of
Agriculture, Ryukoku University, Otsu, Shiga), Tomonori
Okamura (Department of Preventive Medicine and Public Health,
School of Medicine, Keio University, Tokyo), Akira Sekikawa,
Emma JM Barinas-Mitchell (Department of Epidemiology,
Graduate School of Public Health, University of Pittsburgh,
Pittsburgh, PA, USA), Daniel Edmundowicz (Department of
Medicine, Section of Cardiology, School of Medicine, Temple
University, Philadelphia, PA, USA), Takayoshi Ohkubo (Depart-
ment of Hygiene and Public Health, Teikyo University School of
Medicine, Tokyo), Atsushi Hozawa (Department of Preventive
Medicine and Epidemiology, Tohoku Medical Megabank
Organization, Tohoku University, Sendai, Miyagi), Yoshitaka
Murakami (Division of Medical Statistics, Department of Social
Medicine, Toho University, Tokyo), Nagako Okuda (Department
of Health and Nutrition, University of Human Arts and Sciences,
Saitama), Hisatomi Arima (Department of Preventive Medicine
and Public Health, Faculty of Medicine, Fukuoka University,
Fukuoka), Yoshikuni Kita (Faculty of Nursing Science, Tsuruga
Nursing University, Tsuruga, Fukui), Takashi Hisamatsu
(Department of Environmental Medicine and Public Health,
Faculty of Medicine, Shimane University, Izumo, Shimane),
Aya Higashiyama (Research and Development Initiative Center,
National Cerebral and Cardiovascular Center, Suita, Osaka),
Shinya Nagasawa (Department of Epidemiology and Public
Health, Kanazawa Medical University, Kanazawa, Ishikawa),
Koichiro Azuma (Institute for Integrated Sports Medicine School
of Medicine, Keio University, Tokyo), Masahiko Yanagita
(Faculty of Health and Sports Science, Doshisha University,
Kyoto), Robert D. Abbott, Aya Kadota, Seiko Ohno, Maryam
Zaid (Center for Epidemiologic Research in Asia, Shiga
University of Medical Science, Otsu, Shiga), Akira Fujiyoshi,
Naoyuki Takashima, Takashi Kadowaki, Sayaka Kadowaki,
Naoko Miyagawa, Keiko Kondo, Sayuki Torii, Yoshino Saito,
Sentaro Suzuki and Takahiro Ito, Atsushi Satoh, Masahiro
Yamazoe (Department of Public Health, Shiga University of
Medical Science, Otsu, Shiga).
REFERENCES
1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment
of burden of disease and injury attributable to 67 risk factors and risk
factor clusters in 21 regions, 1990–2010: a systematic analysis for
the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–
2260.
2. Ng M, Fleming T, Robinson M, et al. Global, regional, and national
prevalence of overweight and obesity in children and adults during
1980–2013: a systematic analysis for the Global Burden of Disease
Study 2013. Lancet. 2014;384:766–781.
3. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity
and coronary heart disease in women. JAMA. 1998;280:1843–1848.
4. Hadaegh F, Zabetian A, Sarbakhsh P, Khalili D, James WP, Azizi F.
Appropriate cutoﬀ values of anthropometric variables to predict
cardiovascular outcomes: 7.6 years follow-up in an Iranian
population. Int J Obes (Lond). 2009;33:1437–1445.
5. Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoﬀmann U,
Fox CS. Body fat distribution, incident cardiovascular disease,
cancer, and all-cause mortality. J Am Coll Cardiol. 2013;62:921–
925.
6. Mahabadi AA, Massaro JM, Rosito GA, et al. Association of
pericardial fat, intrathoracic fat, and visceral abdominal fat with
cardiovascular disease burden: the Framingham Heart Study. Eur
Heart J. 2009;30:850–856.
7. Shah RV, Murthy VL, Abbasi SA, et al. Visceral adiposity and the
risk of metabolic syndrome across body mass index: the MESA
Study. JACC Cardiovasc Imaging. 2014;7:1221–1235.
8. Rosito GA, Massaro JM, Hoﬀmann U, et al. Pericardial fat, visceral
abdominal fat, cardiovascular disease risk factors, and vascular
calciﬁcation in a community-based sample: the Framingham Heart
Study. Circulation. 2008;117:605–613.
9. Abraham TM, Pedley A, Massaro JM, Hoﬀmann U, Fox CS.
Association between visceral and subcutaneous adipose depots and
incident cardiovascular disease risk factors. Circulation. 2015;132:
1639–1647.
10. Ding J, Kritchevsky SB, Hsu FC, et al. Association between non-
subcutaneous adiposity and calciﬁed coronary plaque: a substudy of
the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2008;88:
645–650.
11. Ladeiras-Lopes R, Sampaio F, Bettencourt N, et al. The ratio
between visceral and subcutaneous abdominal fat assessed by
computed tomography is an independent predictor of mortality and
cardiac events. Rev Esp Cardiol (Engl Ed). 2017;70:331–337.
12. Bell S, Daskalopoulou M, Rapsomaniki E, et al. Association
between clinically recorded alcohol consumption and initial
presentation of 12 cardiovascular diseases: population based cohort
Alcohol Consumption and Fat Deposition
210 j J Epidemiol 2019;29(6):205-212
study using linked health records. BMJ. 2017;356:j909.
13. Foerster M, Marques-Vidal P, Gmel G, et al. Alcohol drinking and
cardiovascular risk in a population with high mean alcohol
consumption. Am J Cardiol. 2009;103:361–368.
14. Ueshima H, Shimamoto T, Iida M, et al. Alcohol intake and
hypertension among urban and rural Japanese populations. J
Chronic Dis. 1984;37:585–592.
15. Tsumura K, Hayashi T, Suematsu C, Endo G, Fujii S, Okada K.
Daily alcohol consumption and the risk of type 2 diabetes in
Japanese men: the Osaka Health Survey. Diabetes Care. 1999;22:
1432–1437.
16. Freiberg MS, Cabral HJ, Heeren TC, Vasan RS, Curtis Ellison R;
Third National Health and Nutrition Examination Survey. Alcohol
consumption and the prevalence of the Metabolic Syndrome in the
US.: a cross-sectional analysis of data from the Third National
Health and Nutrition Examination Survey. Diabetes Care. 2004;27:
2954–2959.
17. Molenaar EA, Massaro JM, Jacques PF, et al. Association of
lifestyle factors with abdominal subcutaneous and visceral adiposity:
the Framingham Heart Study. Diabetes Care. 2009;32:505–510.
18. Kondoh T, Takase H, Yamaguchi TF, et al. Association of dietary
factors with abdominal subcutaneous and visceral adiposity in
Japanese men. Obes Res Clin Pract. 2014;8:e16–e25.
19. Komiya H, Mori Y, Yokose T, Tajima N. Smoking as a risk factor
for visceral fat accumulation in Japanese men. Tohoku J Exp Med.
2006;208:123–132.
20. Kim KH, Oh SW, Kwon H, Park JH, Choi H, Cho B. Alcohol
consumption and its relation to visceral and subcutaneous adipose
tissues in healthy male Koreans. Ann Nutr Metab. 2012;60:52–61.
21. Colditz GA, Giovannucci E, Rimm EB, et al. Alcohol intake in
relation to diet and obesity in women and men. Am J Clin Nutr.
1991;54:49–55.
22. Wannamethee SG, Shaper AG, Whincup PH. Alcohol and adiposity:
eﬀects of quantity and type of drink and time relation with meals.
Int J Obes. 2005;29:1436–1444.
23. Baik I, Shin C. Prospective study of alcohol consumption and
metabolic syndrome. Am J Clin Nutr. 2008;87:1455–1463.
24. Wang L, Lee IM, Manson JE, Buring JE, Sesso HD. Alcohol
consumption, weight gain, and risk of becoming overweight in
middle-aged and older women. Arch Intern Med. 2010;170:453–
461.
25. Wakabayashi I. Age-dependent inverse association between alcohol
consumption and obesity in Japanese men. Obesity. 2011;19:1881–
1886.
26. Tolstrup JS, Halkjaer J, Heitmann BL, et al. Alcohol drinking
frequency in relation to subsequent changes in waist circumference.
Am J Clin Nutr. 2008;87:957–963.
27. Slattery ML, McDonald A, Bild DE, et al. Associations of body fat
and its distribution with dietary intake, physical activity, alcohol,
and smoking in blacks and whites. Am J Clin Nutr. 1992;55:943–
949.
28. Dallongeville J, Marécaux N, Ducimetière P, et al. Inﬂuence of
alcohol consumption and various beverages on waist girth and
waist-to-hip ratio in a sample of French men and women. Int J Obes
Relat Metab Disord. 1998;22:1178–1183.
29. Bergmann MM, Schütze M, Steﬀen A, et al. The association of
lifetime alcohol use with measures of abdominal and general
adiposity in a large-scale European cohort. Eur J Clin Nutr.
2011;65:1079–1087.
30. Ueshima H, Kadowaki T, Hisamatsu T, et al; ACCESS and SESSA
Research Groups. Lipoprotein-associated phospholipase A2 is
related to risk of subclinical atherosclerosis but is not supported
by Mendelian randomization analysis in a general Japanese
population. Atherosclerosis. 2016;246:141–147.
31. Hisamatsu T, Miura K, Arima H, et al; Shiga Epidemiological Study
of Subclinical Atherosclerosis (SESSA) Research Group. Smoking,
smoking cessation, and measures of subclinical atherosclerosis in
multiple vascular beds in Japanese men. J Am Heart Assoc. 2016;5.
32. Okamura T, Tanaka T, Yoshita K, et al. HIPOP-OHP research
group. Speciﬁc alcoholic beverage and blood pressure in a middle-
aged Japanese population: the High-risk and Population Strategy for
Occupational Health Promotion (HIPOP-OHP) Study. J Hum
Hypertens. 2004;18:9–16.
33. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate
alcohol intake and lower risk of coronary heart disease: meta-
analysis of eﬀects on lipids and haemostatic factors. BMJ.
1999;319:1523–1528.
34. McDonald H, Borinskya S, Kiryanov N, Gil A, Helander A, Leon
DA. Comparative performance of biomarkers of alcohol con-
sumption in a population sample of working-aged men in Russia:
the Izhevsk Family Study. Addiction. 2013;108:1579–1589.
35. Fujiyoshi A, Miura K, Kadowaki S, et al; SESSA Research Group.
Lifetime cigarette smoking is associated with abdominal obesity in a
community-based sample of Japanese men: The Shiga Epidemio-
logical Study of Subclinical Atherosclerosis (SESSA). Prev Med
Rep. 2016;4:225–232.
36. Kadowaki T, Sekikawa A, Murata K, et al. Japanese men have larger
areas of visceral adipose tissue than Caucasian men in the same
levels of waist circumference in a population-based study. Int J
Obes. 2006;30:1163–1165.
37. Rössner S, Bo WJ, Hiltbrandt E, et al. Adipose tissue determinations
in cadavers–a comparison between cross-sectional planimetry and
computed tomography. Int J Obes. 1990;14:893–902.
38. DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of
abdominal adiposity to age-related diﬀerences in insulin sensitivity
and plasma lipids in healthy nonobese women. Diabetes Care.
2001;24:925–932.
39. Wheeler GL, Shi R, Beck SR, et al. Pericardial and visceral adipose
tissues measured volumetrically with computed tomography are
highly associated in type 2 diabetic families. Invest Radiol. 2005;40:
97–101.
40. Fox CS, Massaro JM, Hoﬀmann U, et al. Abdominal visceral
and subcutaneous adipose tissue compartments: association with
metabolic risk factors in the Framingham Heart Study. Circulation.
2007;116:39–48.
41. Cigolini M, Targher G, Bergamo Andreis IA, et al. Moderate alcohol
consumption and its relation to visceral fat and plasma androgens in
healthy women. Int J Obes Relat Metab Disord. 1996;20:206–212.
42. Matsushita Y, Nakagawa T, Yamamoto S, et al. Associations of
visceral and subcutaneous fat areas with the prevalence of metabolic
risk factor clustering in 6,292 Japanese individuals: the Hitachi
Health Study. Diabetes Care. 2010;33:2117–2119.
43. Kramer CK, von Mühlen D, Gross JL, Barrett-Connor E. A
prospective study of abdominal obesity and coronary artery calcium
progression in older adults. J Clin Endocrinol Metab. 2009;94:
5039–5044.
44. Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L.
Leptin selectively decreases visceral adiposity and enhances insulin
action. J Clin Invest. 1997;100:3105–3110.
45. Raben A, Agerholm-Larsen L, Flint A, Holst JJ, Astrup A. Meals
with similar energy densities but rich in protein, fat, carbohydrate,
or alcohol have diﬀerent eﬀects on energy expenditure and substrate
metabolism but not on appetite and energy intake. Am J Clin Nutr.
2003;77:91–100.
46. Mulligan K, Khatami H, Schwarz JM, et al. The eﬀects of
recombinant human leptin on visceral fat, dyslipidemia, and
insulin resistance in patients with human immunodeﬁciency virus-
associated lipoatrophy and hypoleptinemia. J Clin Endocrinol
Metab. 2009;94:1137–1144.
47. Inoue K, Maeda N, Kashine S, et al. Short-term eﬀects of liraglutide
on visceral fat adiposity, appetite, and food preference: a pilot
study of obese Japanese patients with type 2 diabetes. Cardiovasc
Diabetol. 2011;10:109.
48. Gianoulakis C, Dai X, Brown T. Eﬀect of chronic alcohol
consumption on the activity of the hypothalamic-pituitary-adrenal
axis and pituitary beta-endorphin as a function of alcohol intake,
age, and gender. Alcohol Clin Exp Res. 2003;27:410–423.
49. Debono M, Prema A, Hughes TJ, Bull M, Ross RJ, Newell-Price J.
Visceral fat accumulation and postdexamethasone serum cortisol
levels in patients with adrenal incidentaloma. J Clin Endocrinol
Sumi M, et al.
J Epidemiol 2019;29(6):205-212 j 211
Metab. 2013;98:2383–2391.
50. Haugvad A, Haugvad L, Hamarsland H, Paulsen G. Ethanol does
not delay muscle recovery but decreases testosterone=cortisol ratio.
Med Sci Sports Exerc. 2014;46:2175–2183.
51. Mårin P, Holmäng S, Jönsson L, et al. The eﬀects of testosterone
treatment on body composition and metabolism in middle-aged
obese men. Int J Obes Relat Metab Disord. 1992;16:991–997.
52. Jung SK, Kim MK, Shin J, Choi BY. A cross-sectional analysis of
the relationship between daily alcohol consumption and serum
adiponectin levels among adults aged 40 years or more in a rural
area of Korea. Eur J Clin Nutr. 2013;67:841–847.
53. Lee JJ, Britton KA, Pedley A, et al. Adipose tissue depots and their
cross-sectional associations with circulating biomarkers of metabolic
regulation. J Am Heart Assoc. 2016;5.
54. Klop B, do Rego AT, Cabezas MC. Alcohol and plasma
triglycerides. Curr Opin Lipidol. 2013;24:321–326.
55. Huang CY, Huang HL, Yang KC, Lee LT, Yang WS, Huang KC,
et al. Serum triglyceride levels independently contribute to the
estimation of visceral fat amount among nondiabetic obese adults.
Medicine (Baltimore). 2015;94:e965.
56. Ruidavets JB, Bataille V, Dallongeville J, et al. Alcohol intake and
diet in France, the prominent role of lifestyle. Eur Heart J. 2004;25:
1153–1162.
57. Bailey BW, Sullivan DK, Kirk EP, Donnelly JE. Dietary predictors
of visceral adiposity in overweight young adults. Br J Nutr. 2010;
103:1702–1705.
Alcohol Consumption and Fat Deposition
212 j J Epidemiol 2019;29(6):205-212
